Back to search

Iceland· IS-EU/1/20/1498/002-003

Trixeo Aerosphere

A formoterol, glycopyrronium bromid und budesonid product containing budesonidum inn,formoterolum inn fúmarat,glycopyrronii bromidum inn, registered in Iceland by AstraZeneca AB*. The same ATC class is registered in 11 of our 19 countries.

ATC R03AL11

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedTrixeo AerosphereATCR03AL11REGISTER NO.IS-EU/1/20/1498/002-0…PACKS LISTED2CHECKEDSeptember 29, 2026

Where it is registered

Formoterol, glycopyrronium bromid und budesonid is registered in 11 of 19 countries.

Countries holding a registration under ATC R03AL11 (formoterol, glycopyrronium bromid und budesonid), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 7 of them publish a price we can compare per daily dose

Formoterol, glycopyrronium bromid und budesonid · ATC R03AL11

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Budesonidum INN,Formoterolum INN fúmarat,Glycopyrronii bromidum INN
Manufacturer
AstraZeneca AB*
Country
Iceland (IS)
ATC code
R03AL11
ATC class
Formoterol, Glycopyrronium bromid und Budesonid
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 2

2 priced
  • ean
    478497
    120 skammtar x1 innö.t
    ISK 11991
  • ean
    593636
    120 skammtar x3 innö.t
    ISK 32138

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ad164b91-4e6f-471a-8421-c2b602cad136
GET /v1/drugs/ad164b91-4e6f-471a-8421-c2b602cad136?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Innúðalyf, dreifa",
  "source": "lyfjastofnun",
  "atc_raw": "R03AL11",
  "marketed": true,
  "strength": "5 míkróg/7,2 míkróg/160 míkróg",
  "ma_number": "EU/1/20/1498/002-003",
  "substance": "Budesonidum INN,Formoterolum INN fúmarat,Glycopyrronii bromidum INN",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "44174"
}

See everything about formoterol, glycopyrronium bromid und budesonid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.